Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -0.26% is 90% above its 5-year average of -2.61%, near the high end of its 5-year range (-11.69%–4.44%).
78.04% above its 12-month average of -1.18%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 3.16%.
NET PROFIT MARGIN
-0.26%
NET PROFIT MARGIN AVG TTM
-1.18%
NET PROFIT MARGIN AVG 3Y
-2.89%
NET PROFIT MARGIN AVG 5Y
-2.61%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+78.04%
CURRENT VS 3Y AVG
+91.00%
CURRENT VS 5Y AVG
+90.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 755 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Innovage Holding Corp.
Market Cap
$1.22B
Net Profit Margin
-0.26%
TTM Avg
-1.18%
3Y Avg
-2.89%
5Y Avg
-2.61%
Market Cap
$1.22B
Net Profit Margin
30.98%
TTM Avg
14.24%
3Y Avg
-62.70%
5Y Avg
-170.15%
Market Cap
$1.21B
Net Profit Margin
-11.08%
TTM Avg
5.67%
3Y Avg
-20.56%
5Y Avg
-46.23%
Market Cap
$1.23B
Net Profit Margin
1.39%
TTM Avg
-16.34%
3Y Avg
-42.24%
5Y Avg
-42.24%
Market Cap
$1.24B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.17B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.15B
Net Profit Margin
-287.84%
TTM Avg
-208.97%
3Y Avg
-281.06%
5Y Avg
-321.48%
Market Cap
$1.15B
Net Profit Margin
2.07%
TTM Avg
2.94%
3Y Avg
0.11%
5Y Avg
-9.38%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | -0.26% | -1.18% | -2.89% | -2.61% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 30.98% | 14.24% | -62.70% | -170.15% |
| MannKind Corporation (MNKD)vs › | $1.21B | -11.08% | 5.67% | -20.56% | -46.23% |
| Omada Health (OMDA)vs › | $1.23B | 1.39% | -16.34% | -42.24% | -42.24% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.00% | 0.00% | 0.00% | 0.00% |
| Kardigan, Inc. (KARD)vs › | $1.26B | 0.00% | 0.00% | 0.00% | 0.00% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -287.84% | -208.97% | -281.06% | -321.48% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 2.07% | 2.94% | 0.11% | -9.38% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
6.4%
Net Profit Margin
-0.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 3.16% |
| 2026-03-31 | -11.69% |
| 2025-12-31 | 4.43% |
| 2025-09-30 | 3.40% |
| 2025-06-30 | -5.22% |
| 2025-03-31 | -5.22% |
| 2024-12-31 | -6.33% |
| 2024-09-30 | -2.40% |
| 2024-06-30 | -0.85% |
| 2024-03-31 | -3.05% |
| 2023-12-31 | -1.82% |
| 2023-09-30 | -5.65% |
| 2023-06-30 | -6.32% |
| 2023-03-31 | -3.84% |
| 2022-12-31 | -5.85% |
| 2022-09-30 | -7.64% |
| 2022-06-30 | -7.35% |
| 2022-03-31 | -1.59% |
| 2021-12-31 | 0.75% |
| 2021-09-30 | 4.44% |
| 2021-06-30 | 3.77% |
| 2021-03-31 | -6.72% |
| 2020-12-31 | 6.17% |
| 2020-09-30 | -32.55% |
| 2020-06-30 | 7.93% |
| 2020-03-31 | 5.62% |
